Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients

  • Ahmed Mohamed Kamel Cairo University, Cairo, Egypt
  • Samar Farghali Farid Cairo University, Cairo, Egypt
  • Ahmed Sherif Attia Cairo University, Cairo, Egypt
  • Maissa El. Raziky Cairo University, Cairo, Egypt
Keywords: rs4588, rs7041, fibrosis, viral load, SVR, Egypt


Introduction: Vitamin D binding protein (VDBP) is a potential modulator of immune response and is associated with clinical progression of many diseases. Our aim was to assess influence of baseline 25-hydroxyvitamin D levels and VDBP single nucleotide polymorphisms (SNPs), rs4588 (C > A) and rs7041 (G > T), on baseline clinical parameters and response to interferon based therapy in chronic hepatitis C patients in Egypt.

Methodology: Genotyping was performed by RFLP (Restriction Fragment Length Polymorphism) in 112 treatment naïve hepatitis C patients and 50 healthy controls. Vitamin D levels were assessed by ELISA. HCV RNA quantification was performed by PCR to assess therapy outcome.

Results: Patients with VDBP WT+ diplotype (3 or 4 VDBP major alleles) had higher viral response rates at weeks 12, 48, and 72 (p = 0.046, 0.034 and 0.029, respectively) and lower base line viral load (p = 0.016). Multivariate logistic regression identified VDBP WT+ diplotype as an independent predictor of sustained viral response (SVR; p = 0.014, RR = 4.716, 95% CI = 1.371 – 16.609). Interestingly, WT- diplotype (less than 3 VDBP major alleles) was associated with significant liver fibrosis (p = 0.045).

Conclusions: VDBP WT+ diplotype is associated with lower baseline viral load and better therapy outcome in HCV treatment naïve patients. The rs4588 genotype is associated with SVR in the Egyptian population.

Author Biographies

Ahmed Mohamed Kamel, Cairo University, Cairo, Egypt

Department of Clinical Pharmacy, Faculty of Pharmacy, Teaching assistant

Samar Farghali Farid, Cairo University, Cairo, Egypt

Department of Clinical Pharmacy, Faculty of Pharmacy, Professor

Ahmed Sherif Attia, Cairo University, Cairo, Egypt

Department of Microbiology and Immunology, Faculty of Pharmacy, Assistant Professor

Maissa El. Raziky, Cairo University, Cairo, Egypt

Department of Endemic Medicine, Faculty of Medicine, Professor

Original Articles